Document:

Incentive Compensation Plan Restricted Stock Award Agree with L C Glasscock

 Exhibit 10.58(e) 
 Schedule A 
 Notice of Restricted Stock Grant 
  

			
	Participant:	  	Larry C. Glasscock
		
	Company:	  	WellPoint, Inc.
		
	Notice:	  	You have been granted the following award of restricted shares of common stock of the Company in accordance with the terms of the Plan and the attached Restricted Stock Award
Agreement.
		
	Plan:	  	WellPoint 2006 Incentive Compensation Plan
		
	Grant:	  	Grant Date: [•]
		  	Number of Shares of Restricted Stock: [•]
		
	Period of Restriction:	  	The Period of Restriction applicable to the number of Shares of your Restricted Stock listed in the “Shares” column below shall commence on the Grant Date and shall lapse on the date
listed in the “Lapse Date” column below.

  

			
	 Shares
	  	 Lapse Date

  
  
  

			
		  	However, in the event that a Change of Control occurs before your Termination, the Period of Restriction shall immediately lapse, causing any restrictions which would otherwise remain on your
Restricted Stock to immediately lapse.
		
	Rejection:	  	If you do not want to accept your Restricted Stock, please return this Agreement, executed by you on the last page of this Agreement, at any time within sixty (60) days after the Grant Date
to WellPoint, Inc., 120 Monument Circle, Indianapolis, Indiana 46204, Attention: Stock Administration. Do not return a signed copy of this Agreement if you accept your Restricted Stock. If you do not return a signed copy of this Agreement
within sixty (60) days after the Grant Date, you will have accepted your Restricted Stock and agreed to the terms and conditions set forth in this Agreement and the terms and conditions of the Plan.

 Restricted Stock Award Agreement 
 This Restricted Stock Award Agreement (this “Agreement”) dated as of the Grant Date (the “Grant Date”) set forth in the Notice of
Restricted Stock Grant attached as Schedule A hereto (the “Grant Notice”) is made between WellPoint, Inc. (the “Company”) and the Participant set forth in the Grant Notice. The Grant Notice is included in and made part of this
Agreement. 
 1. Period of Restriction. The Period of Restriction with respect to the Restricted Stock shall be as set forth in the
Grant Notice (the “Period of Restriction”). The Participant acknowledges that prior to the expiration of the applicable portion of the Period of Restriction, the Restricted Stock may not be sold, transferred, pledged, assigned, encumbered,
alienated, hypothecated or otherwise disposed of (whether voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy)). Upon the expiration of the
applicable portion of the Period of Restriction, the restrictions set forth in this Agreement with respect to the Restricted Stock theretofore subject to such expired Period of Restriction shall lapse, except as may be provided in accordance with
Section 9 hereof. 
 2. Ownership. The Participant agrees that the Participant’s ownership of the Restricted Stock will be
evidenced solely by a “book entry” (i.e., a computerized or manual entry) in the records of the Company or its designated stock transfer agent in the Participant’s name. Upon expiration of the applicable portion of the Period
of Restriction, the Company shall transfer the vested shares to the Participant’s account with the Company’s captive broker. 
 3.
Termination and Forfeiture. 
 (a) Termination. The Participant’s Termination will affect the Restricted Stock in
accordance with Sections 13 and/or 15 of the Employment Agreement entered into by and between the Company and the Participant dated as of December 28, 2005 (the “Employment Agreement”). 
 (b) Termination by the Company For Cause. Notwithstanding the foregoing, if the Participant’s Termination is by the Company For Cause (as
defined in the Employment Agreement), then all Restricted Stock for which the Period of Restriction had not lapsed prior to the date of such Termination shall be immediately forfeited. 
 (c) Other Forfeiture. The Restricted Stock shall be forfeited if the Participant breaches any provision of Section 19 (other than
Section 19(b)) of the Employment Agreement, in which case the Participant shall be subject to the “Return of Consideration” provision contained in Section 19(g) of the Employment Agreement. 
 4. Transferability of the Restricted Stock. The Participant shall have the right to appoint any individual or legal entity in writing, on a
Designation of Beneficiary form as his/her beneficiary to receive any Option (to the extent not previously terminated or forfeited) under this Agreement upon the Participant’s death. Such designation under this Agreement may be revoked by the
Participant at any time and a new beneficiary may be appointed by the Participant by execution and submission to the Company, or its designee, of a revised Designation of Beneficiary form to this Agreement. In order to be effective, a designation of
beneficiary must be completed by the Participant on the Designation of Beneficiary form and received by the Company, or its designee, prior to the date of the Participant’s death. If the Participant dies without such designation, the Option may
be exercised only by the executor or administrator of the Participant’s estate or by a person who shall have acquired the right to such exercise by will or by the laws of descent and distribution. 
 5. Taxes and Withholdings. Upon the expiration of the applicable portion of the Period of Restriction or such earlier dates as the Participant
elects pursuant to Section 83(b) of the Code, or as of which the value of any Shares of Restricted Stock first becomes includible in the Participant’s gross income for income tax purposes, the Participant shall notify the Company if the
Participant wishes to pay to the Company in cash, check or with shares of WellPoint common stock already owned for the satisfaction of any taxes of any kind required by law to be withheld with respect to such Shares; provided, however,
that pursuant to any procedures, and subject to any limitations as the Compensation Committee of the Board of Directors of the Company (“Committee”) may prescribe 

 
and subject to applicable law, if the Participant does not notify the Company in writing at least 14 days prior to the applicable lapse of the Period of
Restriction, then the Participant will satisfy such withholding obligations by withholding Shares otherwise deliverable to the Participant pursuant to the Restricted Stock (provided, however, that the amount of any Shares so withheld shall
not exceed the amount necessary to satisfy required Federal, state, local and non-United States withholding obligations using the minimum statutory withholding rates for Federal, state, local and/or non-U.S. tax purposes, including payroll taxes,
that are applicable to supplemental taxable income). Any such election made by the Participant must be irrevocable, made in writing, signed by the Participant, and shall be subject to any restrictions or limitations that the Committee, in its sole
discretion, deems appropriate. In the event that the Participant elects immediate Federal income taxation with respect to all or any portion of this award of Restricted Stock pursuant to Section 83(b) of the Code, the Participant agrees to
deliver a copy of such election to the Company within ten (10) days after filing such election with the Internal Revenue Service. 
 6.
Rights as a Shareholder. The Participant shall have all rights of a shareholder (including, without limitation, dividend and voting rights) with respect to the Restricted Stock, for record dates occurring on or after the Grant Date and prior
to the date any such Shares of Restricted Stock are forfeited in accordance with this Agreement, except that any dividends or distributions paid in Shares or other securities (including, without limitation, any change in the shares of
Restricted Stock pursuant to Section 4.3 of the Plan) with respect to the Restricted Stock shall, during the Period of Restriction, be deposited with the Company or any holder appointed pursuant to Section 2 hereof, together with a stock
power endorsed in blank or other appropriate instrument of transfer, or credited to the Participant’s book-entry account established under Section 2 hereof, as applicable, and shall be subject to the same restrictions (including, without
limitation, the Period of Restriction) as such Restricted Stock and otherwise considered to be such Restricted Stock for all purposes hereunder. 
 7. No Right to Continued Employment. Neither the Restricted Stock nor any terms contained in this Agreement shall confer upon the Participant any express or implied right to be retained in the employment or service of the Company or
any Affiliate for any period, nor restrict in any way the right of the Company, which right is hereby expressly reserved, to terminate the Participant’s employment or service at any time for any reason. The Participant acknowledges and agrees
that any right to have restrictions on the Restricted Stock lapse is earned only by continuing as an employee of the Company or an Affiliate at the will of the Company or such Affiliate, or satisfaction of any other applicable terms and conditions
contained in the Plan and this Agreement, and not through the act of being hired, being granted the Restricted Stock or acquiring Shares hereunder. 
 8. The Plan. This Agreement is subject to all the terms, provisions and conditions of the Plan, which are incorporated herein by reference, and to such regulations as may from time to time be adopted by the Committee. In the event of
any conflict between the provisions of the Plan and this Agreement, the provisions of the Plan shall control, and this Agreement shall be deemed to be modified accordingly. The Plan and the prospectus describing the Plan can be found on the
Company’s HR intranet. A paper copy of the Plan and the prospectus shall be provided to the Participant upon the Participant’s written request to the Company at WellPoint, Inc., 120 Monument Circle, Indianapolis, Indiana 46204, Attention:
Corporate Secretary, Shareholder Services Department. 
 9. Compliance with Laws and Regulations. 
 (a) The Restricted Stock and the obligation of the Company to sell and deliver Shares hereunder shall be subject in all respects to (i) all
applicable Federal and state laws, rules and regulations and (ii) any registration, qualification, approvals or other requirements imposed by any government or regulatory agency or body which the Committee shall, in its discretion, determine to
be necessary or applicable. Moreover, the Company shall not deliver any certificates for Shares to the Participant or any other person pursuant to this Agreement if doing so would be contrary to applicable law. If at any time the Company determines,
in its discretion, that the listing, registration or qualification of Shares upon any national securities exchange or under any state or Federal law, or the consent or approval of any governmental regulatory body, is necessary or desirable, the
Company shall not be required to deliver any certificates for Shares to the Participant or any other person pursuant to this Agreement unless and until such listing, registration, qualification, consent or approval has been effected or obtained, or
otherwise provided for, free of any conditions not acceptable to the Company. 

 (b) The Shares received upon the expiration of the applicable portion of the Period of Restriction shall
have been registered under the Securities Act of 1933 (“Securities Act”). If the Participant is an “affiliate” of the Company, as that term is defined in Rule 144 under the Securities Act (“Rule 144”), the Participant
may not sell the Shares received except in compliance with Rule 144. Certificates representing Shares issued to an “affiliate” of the Company may bear a legend setting forth such restrictions on the disposition or transfer of the Shares as
the Company deems appropriate to comply with Federal and state securities laws. 
 (c) If, at any time, the Shares are not registered under
the Securities Act, and/or there is no current prospectus in effect under the Securities Act with respect to the Shares, the Participant shall execute, prior to the delivery of any Shares to the Participant by the Company pursuant to this Agreement,
an agreement (in such form as the Company may specify) in which the Participant represents and warrants that the Participant is purchasing or acquiring the shares acquired under this Agreement for the Participant’s own account, for investment
only and not with a view to the resale or distribution thereof, and represents and agrees that any subsequent offer for sale or distribution of any kind of such Shares shall be made only pursuant to either (i) a registration statement on an
appropriate form under the Securities Act, which registration statement has become effective and is current with regard to the Shares being offered or sold, or (ii) a specific exemption from the registration requirements of the Securities Act,
but in claiming such exemption the Participant shall, prior to any offer for sale of such Shares, obtain a prior favorable written opinion, in form and substance satisfactory to the Company, from counsel for or approved by the Company, as to the
applicability of such exemption thereto. 
 10. Notices. All notices by the Participant or the Participant’s assignees shall be
addressed to WellPoint, Inc., 120 Monument Circle, Indianapolis, Indiana 46204, Attention: Stock Administration, or such other address as the Company may from time to time specify. All notices to the Participant shall be addressed to the Participant
at the Participant’s address in the Company’s records. 
 11. Other Plans. The Participant acknowledges that any income
derived from the Restricted Stock shall not affect the Participant’s participation in, or benefits under, any other benefit plan or other contract or arrangement maintained by the Company or any Affiliate. 
  

			
	WELLPOINT, INC.
		
	By:	 	  

	Printed:	 	William J. Ryan
	Its:	 	Chairman, Compensation Committee
		 	WellPoint, Inc. Board of Directors

 I DO NOT accept this Restricted Stock: 
  

			
	Signature:	 	  

		 	Larry C. Glasscock
		
	Date:WellPoint, Inc. Executive Salary Continuation Plan effective January 1, 2006

 Exhibit 10.59 
 WellPoint, Inc. 
 Executive Salary Continuation Plan 
 Effective January 1, 2006 

 Article 1: Definitions 
 Capitalized terms used in the Plan have the following meanings: 
  

	1.1	“Authorized Health Care Provider” means a person who is licensed to practice medicine and such other persons as are included by operation of state law. In no
circumstances will a family member of an executive be an Authorized Health Care Provider for purposes of that executive’s claim for benefits under this Plan. 

  

	1.2	“Eligible Executive” means an individual with a WellPoint, Inc. title of Vice President or above who has completed 90 days of active employment (at any level). In
no event will an executive be eligible for benefits under this Plan if he or she is eligible to receive disability benefits under another plan, contract, or other employment arrangement offered by the Employer. An Eligible Executive’s coverage
under the Plan ends upon the date his or her employment with the Employer terminates for any reason other than a termination which qualifies for severance benefits under any severance arrangement of the Employer. 

  

	1.3	“Employer” means WellPoint, Inc. (“WellPoint”) and its subsidiaries and affiliates. 

  

	1.4	“Leave of Absence Team” or “LOA Team” means the division of HRSolutions to which the Employer has delegated operational responsibility for the Plan.

  

	1.5	“Plan” means this WellPoint, Inc. Executive Salary Continuation Plan, as now in effect and as hereafter amended from time to time. 

  

	1.6	“Disability” means a medical or behavioral health condition which is not work related, which continues for more than seven consecutive days, and which results in an
Eligible Executive’s inability to perform the essential duties of his or her job. The Employer will establish such reasonable procedures as in its discretion it deems appropriate to determine whether a Disability exists under the terms of the
Plan. These procedures may include review of medical records by the LOA Team or its designee. 

  

	1.7	“Disability Absence” means a leave of absence for which salary continuation is provided under the terms of this Plan. 

  

	1.8	“New Period of Disability” means (1) when an Eligible Executive returns to work from a Disability Absence for at least one full business day and later
qualifies for benefits under this Plan due to an unrelated condition; or (2) when an Eligible Executive returns to work from a Disability Absence for 90 or more days and subsequently begins another Disability Absence, whether or not for the
same or a related condition. 

  

	1.9	“Recurrent Disability” means (1) when an Eligible Executive returns to work after a Disability Absence without exhausting the 180-day maximum benefit under
this Plan and again becomes disabled from the same or a related condition within 90 calendar days of the end of the prior Disability Absence; (2) when an Eligible Executive incurs additional absences within 90 calendar days of a prior return to
work as a result of the same or a related condition; or (3) when a subsequent period of Disability begins for an unrelated condition before the Eligible Executive completes one full day of work following the prior Disability Leave.

  

 2 

 Article 2: Plan Benefits 
 2.1 Filing a Claim for Benefits  
 To begin the process for obtaining benefits under the Plan, an Eligible Executive must notify the Leave of
Absence Team of his or her disability and request a claim form. This step is called the Initial Notice. An Eligible Executive may appoint an authorized representative to make the Initial Notice and/or to take any other actions on his or her behalf.

 The Eligible Executive must return the completed claim form to the LOA Team within 21 calendar days of the Initial Notice. Failure to return the completed
claim form within this time period will result in a denial of benefits unless the Eligible Executive submits credible evidence that the delay was reasonable due to circumstances beyond his or her control. 
 Benefits may be provided retroactively for a period of leave that occurred up to 30 calendar days prior to the Initial Notice to the LOA Team. Benefits are not available
for portions of leaves that occurred more than 30 days prior to the Initial Notice. 
 2.2 The Claim Determination Process  
 The LOA Team reviews the completed claim form and determines whether it contains sufficient information to approve or deny benefits. The LOA Team requires a certification
substantiating the necessity and anticipated duration of the leave from an Authorized Health Care Provider who is treating the Eligible Executive for the condition for which the benefits are requested. The LOA Team may require such additional
medical records and/or a second or third medical opinion from an Authorized Health Care Provider of its choice as it deems appropriate to determine a claim. In reaching a decision, the LOA Team will consider the diagnosis and nature of health care
being received. 
 To receive benefits under the Plan, an Eligible Executive must have a non-work related total disability that lasts at least eight full
consecutive days, or a partial disability as explained in Section 2.3. For the purposes of this Plan, a total disability is a condition which renders the Eligible Executive unable to perform substantially all of the normal duties of his or her
job. Unless an exception is warranted due to reasonable cause, to qualify for benefits the Eligible Executive must receive treatment for the disabling condition within seven days of the last day worked and receive continuing treatment thereafter for
the condition. In all cases, for benefits to be received, the effect of the care must be of demonstrable medical value for the disabling condition to effectively attain and/or maintain maximum medical improvement. Maximum medical improvement is the
level at which, based on reasonable medical probability, further material recovery from, or lasting improvement to, an injury or sickness can no longer be reasonably anticipated. 
 A complete claim form accompanied by a provider certification and any other necessary medical information will be approved or denied within 45 days of receipt. In the event an incomplete claim is submitted, meaning
that additional information is needed, the LOA Team will notify the Eligible Executive of the additional information or documentation necessary to make a decision. Notice to the Eligible Executive of the need for additional information will suspend
the running of the 45-day decision period. The 45-day decision period will begin running again when the LOA Team receives the additional information. The LOA Team will provide up to two 30-day periods for submission of the necessary information. If
sufficient information is not submitted within that time period for the LOA Team to make a decision on the claim, the claim is treated as denied. 
  

 3 

 When a claim for Disability benefits is approved, the Eligible Executive is notified of the duration of the approved
benefit period. When a claim is denied, the Eligible Executive is notified of the reason for the denial, including a description of any additional material or information necessary for the claim to be approved, with an explanation of why such
additional information or material is necessary. 
 Additionally, if an internal rule, guideline, protocol or other criterion was relied upon in making the
denial decision, that criterion will either be included in the denial notice or the notice will state that such a criterion was relied upon and is available without charge to the Eligible Executive upon request. 
 2.3 Commencement and Duration of Benefits  
 The Plan provides
Eligible Executives with benefits under the Plan beginning on the eighth consecutive day of an absence due to a Disability. If an Eligible Executive does not remain completely disabled during the seven day waiting period, he or she will not qualify
for benefits under the Plan. During this waiting period, the Eligible Executive will be required to use any available PTO time or other supplemental disability time during the waiting period to the extent consistent with applicable law. 

When a claim for Disability benefits is approved, the approval notice will define the period of approved benefits. The benefit period will be determined based on the
certification received from the Authorized Health Care Provider, the nature and expected duration of the disability and other relevant factors. 
 If the
Disability continues past the initial period of approved benefits, the Eligible Executive may file a claim for an extension of benefits, together with a certification from an Authorized Health Care Provider in support of the extension. Claims for
extension will be reviewed and determined in accordance with the process set forth in Section 2.2 above. 
 The maximum duration of benefits under the
Plan is 180 calendar days, inclusive of the seven day waiting period. Partial days are counted as whole days for the purpose of computing the 180 day maximum. If the Eligible Executive continues to be disabled after 180 days and has elected coverage
under WellPoint’s Long Term Disability Plan, he or she may begin to receive benefits under that plan upon exhaustion of Disability benefits and approval of the long term disability claim. 
 Recurrent Disabilities are treated as extensions of the first Disability Absence. Satisfaction of the waiting period for the first period of Disability applies to
Recurrent Disabilities, so benefits may commence without a waiting period. A single 180-day maximum benefit period applies to an initial Disability Absence and all Recurrent Disabilities. The LOA Team determines in its discretion whether a
subsequent condition is the same as or related to the initial condition. 
 For a New Period of Disability, a new waiting period will be imposed before
Disability benefits commence, and a new 180-day maximum benefit period will apply. 
 2.4 Benefit Levels 
 The benefit for total disability under the Plan consists of 100% of weekly base salary. 
 To receive benefits for a partial disability, an Eligible Executive must first have a period of total disability which meets the criteria set forth in Section 2.2,
including a duration of at least eight consecutive days. This eight-day period cannot be satisfied with days of partial attendance. 
  

 4 

 Following the period of total disability, the Authorized Health Care Provider who is treating the disabling condition
must provide proof satisfactory to the LOA Team that the Eligible Executive is unable to perform substantially all of the normal duties of his or her job for a portion of the period that comprises his or her normal weekly work schedule. The
Authorized Health Care Provider must submit in writing to the LOA Team the number of hours which the Eligible Executive can work or a weekly reduced set schedule. 
 The partial disability period must begin within 30 calendar days of the date a covered total disability ends and while the Eligible Executive is eligible for benefits under the Plan. 
 Unless an exception is warranted due to reasonable cause, during the partial disability period the Eligible Executive must receive continuing treatment for the disabling
condition. In all cases, for benefits to be received, the effect of the care must be of demonstrable medical value for the disabling condition to effectively attain and/or maintain maximum medical improvement. Maximum medical improvement is the
level at which, based on reasonable medical probability, further material recovery from, or lasting improvement to, an injury or sickness can no longer be reasonably anticipated. 
 If the Employer can reasonably accommodate an Eligible Executive’s restrictions due to a disability to permit the Eligible Executive to return to work, the Eligible Executive will not be eligible for benefits
under the Plan and will be expected to return to work. 
 2.5 Exclusions 
 This Plan does not provide benefits for a disability caused by or resulting from any of the following: 
  

	•	 	Declared or undeclared war; 

  

	•	 	Participation in criminal misconduct; 

  

	•	 	Service in the armed forces of any country or combination of countries for three weeks or more or in a civilian unit serving with such forces; 

  

	•	 	Elective or cosmetic surgery*; 

  

	•	 	Injury, illness or other condition which qualifies for workers’ compensation benefits; 

  

	•	 	Active participation in a riot or insurrection; 

  

	•	 	Any cause which does not require the active treatment of an Authorized Health Care Provider; 

  

	•	 	Sex transformation surgery and related services or the reversal thereof; 

  

	•	 	Attempted suicide while sane or insane; or 

  

	•	 	Intentional self-inflicted injury or sickness. 

	*	Benefits are provided for a disability resulting from procedures to restore a bodily function or correct a deformity resulting from disease, accidental injury or prior therapeutic
process. 

 2.6 Termination of Benefits 
 Disability benefits will end when the first of the following occurs: (1) the disability ends; (2) the 180-day maximum benefit is exhausted as set forth above; (3) the Eligible Executive’s coverage under the Plan ends as
set forth in Section 1.2. 
  

 5 

 Article 3: Privacy Rights 
 The Employer or its designee will need to access personal information, including medical information, in order to administer benefits under the Plan. The use and disclosure of medical information is performed in accordance with applicable
laws. 
 Article 4: General Provisions 
 4.1 Amendment
or Termination of the Plan 
 WellPoint has the right to amend or terminate the Plan at any time. 
 4.2 Non-Alienation and Assignment 
 No benefit under this Plan shall
be subject to anticipation, sale, assignment, transfer, encumbrance, pledge, charge, attachment, garnishment, execution, or any other voluntary or involuntary alienation. 
 4.3 Successors and Assigns 
 This Plan shall be binding upon the successors and
assigns of WellPoint. 
  

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}]]